Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.42% to 10446.35, DAX +0.25% to 24914.88, CAC40 (0.35%) to 8311.74, STOXX 600 (0.13%) to 617.70

Feb 13 ,2026

  • Synopsis:

    • European equity markets closed mixed. Banks, personal goods and retail were the worst performing sectors, while technology, industrials and health care outperformed. Follows mixed performance on Thursday.

    • Euro appreciation increasingly becoming a focal point for ECB policy debate, with Governing Council member Kazaks warning it will take time to see full impact. Reuters cited latest forecast, which showed an improvement in earnings expectations with European companies expected to report a 1.1% in Q4 2025. While this would still be the worst in past seven quarters, it represents an increase on the 3.1% drop forecast a week ago. Elsewhere, BoE chief economist Pill hardening view on inflation backdrop (Bloomberg). Highlighted that rates are a "little too low" to bring inflation down and should be held at 3.75%. While inflation is forecast to hit the BoE's target in Q2 due to government cost-of-living measures, Pill pointed out that without one-off effect inflation would be ~2.5% - a sign that underlying price pressures remain persistent. In latest trade developments, attention on report Trump planning to scale back some levies on steel and aluminum as part of its broader affordability push.

    • On the macro data front, Eurozone second estimate of Q4 GDP confirmed at 0.3%, trade surplus widened in December. German wholesale prices jumped in January, but not a market mover. Spanish final inflation slightly lower than flash though unlikely to change Eurozone outlook and ECB rate narrative. Swiss CPI steady in January.

    • The Munich Security Conf takes place over the weekend until Sun. Chancellor Merz opening speech and then available for questions, other participants include Norway's PM Støre, EU's von der Leyen, Jørgensen, Kallas and Hansen. US's Rubio to meet Zelenskyy in Munich as more Russian strikes leave thousands without power, with the Ukrainian leader ruling out referendum on 'bad deal'.

    • In corporate news flow today, out of France, Safran (SAF.FP), L'Oreal (OR.FP), Ubisoft Entertainment (UBI.FP), Capgemini (CAP.FP) reported FY numbers. In the Nordics, Tomra Systems (TOM.NO), Norsk Hydro (NHY.NO), Fingerprint Cards (FING.B.SS), Apetit (APETIT.FH), Koskisen (KOSKI.FH), Norwegian Air Shuttle (NAS.NO) posted latest Q4/FY results. In the UK, NatWest Group (NWG.LN) reported FY earnings. Reuters reports Comcast's (CMCSA), ITV (ITV.LN) tie-up talks have slowed amid macro concerns and challenges related to a Studios spin. In the afternoon, Interpump Group (IP.IM) closed (22.2% lower after the company reported Q4 earnings with net income €37.4M vs FactSet €50.3M.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Technology +1.72%, Ind Goods & Svcs +0.83%, Health Care +0.73%, Financial Svcs +0.60%, Autos & Parts +0.41%, Media +0.30%, Construct & Mtls +0.15%, Oil & Gas +0.11%, Telecom +0.09%, Chemicals (0.03%)

      • Underperformers:

        • Banks (2.78%), Persnl & HHold Goods (0.82%), Retail (0.54%), Food & Beverage (0.49%), Insurance (0.48%), Basic Resources (0.41%), Utilities (0.40%), Travel & Leisure (0.20%), Real Estate (0.13%)

    • Macro:

      • Kazaks says ECB has yet to see full impact of euro appreciation - Bloomberg

      • Dispute between Germany and France is paralyzing Europe - Handelsblatt

      • EU leaders vow to accelerate single market, in struggle to compete with US and China - Reuters

      • French conservative leader Retailleau announces presidential run - Politico

      • UK PM Starmer ousts cabinet secretary in clear-out of top team - Guardian

      • Starmer to call for multinational defense initiative to cut cost of rearmament - FT

    • Company news:

      • Notable Gainers

        • +17.0% KDV.B.SS (KDventures AB SEK0.33, +0.05) -- Q4 earnings

        • +16.1% NETI.B.SS (Net Insight SEK2.32, +0.32) -- CEO acquires 5,200,000 shares at SEK 10M value

        • +15.3% NCAB.SS (NCAB Group SEK44.78, +5.94) -- Q4 earnings

        • +14.5% HEIJM.NA (Heijmans €78.80, +10.00) -- FY earnings

        • +13.3% UBI.FP (Ubisoft Entertainment €4.66, +0.55) -- Q3 revenue

        • +8.2% SAF.FP (Safran €332.40, +25.10) -- FY earnings

        • +8.0% ALLIGO.B.SS (Alligo SEK135.00, +10.00) -- Q4 earnings

        • +7.9% POSTI.FH (Posti Group €8.90, +0.65) -- Q4 earnings

        • +7.6% TPE.GR (PVA TePla €24.38, +1.72) -- BNP Paribas Exane upgrade

        • +7.2% KALMAR.FH (Kalmar €44.58, +3.00) -- Q4 earnings

        • +6.2% KIT.NO (Kitron NOK92.90, +5.40) -- DNB Carnegie upgrade

        • +5.6% AFK.NO (Arendals Fossekompani NOK169.00, +9.00) --

          • Q4 earnings

          • TA Associates enters as new strategic investment partner in Volue; to receive cash proceeds of ~€38M

        • +5.6% CAP.FP (Capgemini €105.35, +5.61) -- FY earnings

        • +5.1% DOC.AV (DO & CO €210.00, +10.20) -- Kepler Cheuvreux upgrade

        • +5.1% HARVIA.FH (Harvia €37.30, +1.80) -- DNB Carnegie upgrade

        • +5.0% ELTEL.SS (Eltel SEK9.24, +0.44) -- Q4 earnings

        • +4.3% BORG.SS (Bjorn Borg SEK61.00, +2.50) -- Q4 earnings

        • +4.0% ETL.FP (Eutelsat Communications €2.22, +0.09) -- H1 earnings

        • +3.8% CINPHA.SS (Cinclus Pharma Holding SEK17.32, +0.64) -- FDA has provided a positive assessment of the company's nonclinical development plan for linaprazan glurate

        • +3.2% CABP.LN (CAB Payments Holdings £0.78, +0.02) -- responds to Helios Consortium's announcement from 12-Feb

        • +3.1% SDI.LN (SDI Group £0.84, +0.02) -- acquisition of PRP Optoelectronics Ltd for a net consideration of £9.3M

        • +2.8% ENENTO.FH (Enento Group €14.66, +0.40) -- Q4 earnings

        • +2.7% JEN.GR (Jenoptik €27.74, +0.72) -- prelim FY earnings

        • +2.2% MUX.GR (Mutares SE & Co KGaA €31.90, +0.70) -- to acquire the flooring business of Hamberger Industriewerke

        • +2.2% MEKKO.FH (Marimekko €11.40, +0.24) -- Inderes upgrade

        • +1.9% NXQ.LN (Nexteq £0.76, +0.01) -- secures first customer win and initial software license purchase order for Launchpad

      • Notable Decliners

        • -21.1% LECN.SW (Leclanché CHF0.11, -0.03) -- facing short-term liquidity constraints, Leclanché delays paying Jaunary salaries

        • -17.7% IP.IM (Interpump Group €41.79, -9.01) -- Q4 earnings

        • -13.4% ELK.NO (Elkem NOK25.00, -3.88) -- Q4 earnings; to sell majority of Silicones division to Bluestar

        • -9.7% BOUV.NO (Bouvet NOK49.10, -5.30) -- Q4 earnings

        • -8.9% PBB.GR (Deutsche Pfandbriefbank €3.69, -0.36) -- prelim FY earnings

        • -8.7% TOM.NO (Tomra Systems NOK122.40, -11.60) -- Q4 earnings

        • -8.3% CEM.IM (Cementir Holding €16.64, -1.50) -- FY earnings

        • -7.7% 4C.SS (4C Group SEK10.80, -0.90) -- Q4 earnings

        • -7.4% TFI.FP (TF1 €7.36, -0.59) -- Q4 earnings

        • -6.0% NTEK.B.SS (Novotek SEK75.20, -4.80) -- Q4 earnings

        • -5.9% NHY.NO (Norsk Hydro NOK85.82, -5.42) -- Q4 earnings

        • -5.3% RELAIS.FH (Relais Group €16.00, -0.90) -- Q4 earnings

        • -4.9% OR.FP (L'Oreal €372.50, -19.15) -- FY earnings

        • -4.6% LINK.NO (LINK Mobility Group Holding NOK21.90, -1.05) -- Carnegie downgrade; Handelsbanken upgrade

        • -4.5% TEKNA.NO (Tekna Holding NOK3.82, -0.18) -- comments on concluded appeal in Canada

        • -4.3% RWE.GR (RWE €49.86, -2.24) -- Bernstein downgrade

        • -4.3% HUMBLE.SS (Humble Group SEK7.27, -0.33) -- Q4 earnings

        • -3.8% SMCRT.NO (SmartCraft NOK16.35, -0.65) -- FY earnings

        • -3.7% ACAST.SS (Acast SEK26.30, -1.00) -- Barclays downgrade

        • -3.7% AFG.NO (AF Gruppen NOK184.00, -7.00) --

          • Q4 earnings

          • to buy 70% stake in H.A. Bygg Entreprenad; enterprise value for 100% of shares is up to SEK140M on debt-free basis

        • -3.4% GLA1V.FH (Glaston €1.14, -0.04) -- Q4 earnings

        • -3.0% ODF.NO (Odfjell NOK122.20, -3.80) -- Arctic Securities and Kepler Cheuvreux downgrade

        • -2.6% KCC.NO (Klaveness Combination Carriers NOK86.50, -2.30) -- Q4 earnings

        • -2.3% ALICA.FP (ICAPE Holding €5.84, -0.14) -- Kepler Cheuvreux downgrade

        • -2.2% APAM.NA (Aperam €41.82, -0.92) -- Q4 earnings

        • -1.9% PROF.B.SS (ProfilGruppen SEK105.50, -2.00) -- FY earnings; strengthens its organization as part of its transformation agenda

        • -1.8% TLT1V.FH (Teleste €3.78, -0.07) -- Q4 earnings

    • EU companies reporting Monday:

      • Earnings:

        • Benelux: Theon International (THEON.NA)

        • DACHs: Sartorius (SRT3.GR)

        • France: Vicat (VCT.FP)

        • Nordics: Ratos (RATO.B.SS), Aspo (ASPO.FH), Framery Group (FRAMERY.FH)

      • Trading Update:

        • France: Inventiva (IVA.FP)

      • Traffic: Aeroports de Paris (ADP.FP)

  • Data:

    • Economics:

      • Switzerland Jan CPI +0.1% y/y vs consensus +0.1%, prior +0.1%

      • Spain Jan CPI +2.3% y/y vs preliminary +2.4%

      • Eurozone

        • Q4 GDP (2nd estimate) +1.3% y/y vs preliminary +1.3%; +0.3% q/q vs preliminary +0.3%

        • Dec trade balance €12.6B vs consensus €12.0B, prior revised €9.3B from €9.9B

    • Markets:

      • WTI Crude (Mar 26): ($0.09) or (0.14%) to $62.75

      • €-$ +0.0001 or +0.01% to 1.1873

      • £-$ +0.0010 or +0.07% to 1.3633

      • €-£ (0.0008) to 0.8708

      • S&P 500 +0.34%

      • Performance year-to-date

        • FTSE 100: +5.19%

        • DAX: +1.73%

        • CAC: +1.99%

        • MIB: +1.08%

        • Stoxx 600: +4.31%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE